Health News Releases

January 29, 15:24

Galderma Unveils ‘Wake Up To Restylane’, Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty

Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To Restylane’, a global campaign that showcases Restylane as an everyday beauty ally. Aligned with the growing de

January 29, 10:40

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. Th

January 26, 16:11

Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced financial results for the fourth quarter and fiscal year 20

January 25, 13:30

Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES

Concept Medical Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.conceptmedical.com%2F&esheet=54401002&newsitemid=20260121338054&lan=en-US&anchor=Concept+Medical+Inc.&index=

January 25, 09:30

Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis

Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and whole transcriptome analysis

January 23, 09:07

Innovative Research Unveils Potential of Pharmaceutically Processed Mica in Cancer Treatment

A South Korean research team has discovered that pharmaceutically processed mica (PMC), a mineral traditionally used in medicine, may help suppress the growth of non-small cell lung cancer (NSCLC) cel

January 23, 08:30

SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the

January 22, 14:30

International Zinc Association Partners With Pharmanova to Save Children in Zambia

Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zinc.org%2F&esheet=54398808&newsite

January 22, 09:16

Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership

Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 neuromo

January 21, 15:20

Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accre

January 21, 13:50

Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health

Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization’s work on oral health. The four-year funding commitment will help exp

January 21, 11:50

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will le

January 21, 10:40

WHOOP Becomes Official Health and Fitness Wearable Partner and Team Partner of Scuderia Ferrari HP

WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%3Futm_source%3DPR%26utm_medium%3DPR%26utm_campaign%3DSR_A&esheet=54399604&newsitemid=20260119602892&lan=en-US&anc

January 19, 17:04

Syngenta to Address Global Agricultural Challenges at WEF, Championing AI to Empower Farmers and Create Open Technology Access

As farmers globally grapple with unprecedented economic, geopolitical, and environmental pressures; the agricultural sector faces a continued contraction. An alarming decrease in active farms worldwid

January 18, 13:45

WEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I-IV Trial Delivery Capabilities

WEP Clinical (WEP) (https://www.wepclinical.com/), a full-service contract research organization (CRO), announces the acquisition of Siron Clinical (Siron) (https://sironclinical.com/), a Netherlands-

January 16, 15:10

Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

Agenus Inc. (https://www.agenusbio.com/) (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences

January 16, 11:20

QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovig

January 15, 15:10

Notice Concerning Change of Representative Executive Officer

H.U. Group Holdings, Inc. (the Company) today announced that it has resolved, at a meeting of the Board of Directors held on January 14, 2026, to change the Company’s Representative Executive Officer

January 15, 10:40

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking

Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures wit

January 15, 10:03

Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference

Samsung Epis Holdings (KRX: 0126Z0) today shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference. “2026 is a monumental year for us, as we enter into a new chapter for

January 14, 17:05

France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas

Agenus Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.agenusbio.com&esheet=54393958&newsitemid=20260112699965&lan=en-US&anchor=Agenus+Inc&index=1&md5=e3584ab25f74ab4a2ec4f1

January 14, 16:32

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics

Galderma (SIX: GALD) will present data on its innovative and industry-leading neuromodulator portfolio at the TOXINS 2026 International Conference in Madrid, Spain from January 14-17, 2026. The compan

January 14, 15:20

BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54394840&newsitemid=20260113426214&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md

January 13, 14:00

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement desig

January 13, 09:02

FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic tr

News by Region

News by Industry